boston.com Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Comments
Send your comments and tips to whitecoat@globe.com
Categories


Blogger
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Contributors
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
Week of: May 20
Week of: May 13
Week of: May 6
Week of: April 29
Week of: April 22
Week of: April 15

« Hebrew Rehab outbreak waning | Main | Today's Globe: doctors and drug companies, hospital earnings, volunteers, VA clinic problems, smoking and attention »

Thursday, March 22, 2007

Creatine to be studied in new Parkinson's trial

By Carey Goldberg, Globe Staff

Federal researchers announced early today that theyíre launching a nationwide trial to see whether creatine, a supplement long favored by body-builders, can slow the effects of Parkinsonís Disease.

The National Institute of Neurological Disorders and Stroke is aiming to enroll more than 1,700 Parkinsonís patients at sites around the country, including two in Boston: one at Brigham and Womenís Hospital and one at Beth Israel Deaconess Medical Center.

Parkinsonís is a degenerative illness that affects more than a million Americans. Initial studies suggest that creatine may slow the degeneration. Some drugs can help relieve the tremors and other symptoms of Parkinsonís, but none seems able to stop the disease from progressively worsening.

Patients in the clinical trial will be expected to participate for from five to seven years.

More info: 1-800-352-9424; info@parkinsontrial.org.

Posted by Karen Weintraub at 12:12 AM
Sponsored Links